Literature DB >> 10846339

Medical abortion in China.

S Wu1.   

Abstract

This paper reviews the literature on early medical abortion in China. Mifepristone was approved for termination of pregnancy up to 49 days' gestation in China in 1986. The commonly accepted regimens are 150 mg mifepristone administered in several small doses or a single 200 mg dose followed by 0.6 mg oral misoprostol. Complete abortion rates are 90% to 97%. Ultrasound is strongly recommended to rule out ectopic pregnancy. Patients remain in the clinic for four to six hours after misoprostol. If the fetal sac is not expelled during the four-hour observation, the second dose of 0.4 mg misoprostol is given in many of the clinics. Rates of emergency curettage ranged from less than 1% to 4%, and rates of blood transfusion were less than 1%. The major complication of concern is undiagnosed ectopic pregnancy. The Chinese experience has shown that medical abortion is well accepted as an alternative to surgical intervention when provided under medical supervision and administrative monitoring.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10846339

Source DB:  PubMed          Journal:  J Am Med Womens Assoc (1972)        ISSN: 0098-8421


  4 in total

Review 1.  Family planning technical services in China.

Authors:  Shang-Chun Wu
Journal:  Front Med China       Date:  2010-08-12

2.  Medical termination of pregnancy in general practice in Australia: a descriptive-interpretive qualitative study.

Authors:  Angela J Dawson; Rachel Nicolls; Deborah Bateson; Anna Doab; Jane Estoesta; Ann Brassil; Elizabeth A Sullivan
Journal:  Reprod Health       Date:  2017-03-14       Impact factor: 3.223

3.  Repeated abortion affects subsequent pregnancy outcomes in BALB/c mice.

Authors:  Fang Lv; Xiangbo Xu; Shucheng Zhang; Lili Wang; Ning Wang; Bin He; Jiedong Wang
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

4.  Barriers to access prevention of mother-to-child transmission for HIV positive women in a well-resourced setting in Vietnam.

Authors:  Thu Anh Nguyen; Pauline Oosterhoff; Yen Pham Ngoc; Pamela Wright; Anita Hardon
Journal:  AIDS Res Ther       Date:  2008-04-17       Impact factor: 2.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.